Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice

被引:40
作者
Baumhaekel, Magnus [1 ]
Custodis, Florian [1 ]
Schlimmer, Nils [1 ]
Laufs, Ulrich [1 ]
Boehm, Michael [1 ]
机构
[1] Univ Klinikum Saarlandes, Innere Med Klin 3, D-66421 Homburg, Germany
关键词
Heart rate; Ivabradine; Endothelial function; Erectile dysfunction; CORONARY-ARTERY-DISEASE; HIGH-RISK PATIENTS; CARDIOVASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; CORPUS CAVERNOSUM; OXIDATIVE STRESS; IRBESARTAN; BEAUTIFUL;
D O I
10.1016/j.atherosclerosis.2010.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the effect of heart rate reduction with ivabradine on atherosclerotic lesions and erectile dysfunction. Methods: Two different treatment regimes with ivabradine were applied in wild-type (C57/B6) and ApoE(-/-)-mice to study effects of ivabradine on erectile function and atherosclerosis in animals with and without present endothelial dysfunction. Preventive effects of ivabradine were evaluated in animals fed a high-cholesterol diet in parallel to treatment with ivabradine (orally via chow, 10 mg/kg per day). The other treatment regime started treatment with a high-cholesterol diet for 4 weeks to induce endothelial dysfunction. Thereafter, treatment with ivabradine (orally via chow, 15 mg/kg per day) was started in ApoE(-/-) mice for 3 months. Vital parameters were measured using the tail-cuff method. Erectile function was assessed by pharmacological stimulation of corpora cavernosa in organ bath chambers. Atherosclerotic plaque formation, oxidative stress, eNOS and collagen content were determined. Results: Treatment with ivabradine significantly reduced heart rate (p < 0.01), with no effect on blood pressure. Aortic atherosclerotic lesion size decreased with ivabradine in both treatment regimes (p < 0.05). Endothelium-dependent relaxation of corpora cavernosa significantly decreased in ApoE(-/-)-mice witha restoration by ivabradine in prevention and reversal. Dihydroethidium-stained penile sections(p < 0.05) and lipid peroxidase assay(p < 0.05) revealed a reduction in superoxide production in ivabradine-treated animals. Penile eNOS-expression increased and collagen content significantly decreased (p < 0.01) in ivabradine-treated animals. Conclusion: Ivabradine improves penile endothelial function by reduction of oxidative stress and penile fibrosis. Beneficial effects were achieved in prevention and manifest endothelial dysfunction. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 29 条
[11]   Contributions of heart rate and contractility to myocardial oxygen balance during exercise [J].
Colin, P ;
Ghaleh, B ;
Monnet, X ;
Su, JB ;
Hittinger, L ;
Giudicelli, JF ;
Berdeaux, A .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (02) :H676-H682
[12]   Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice [J].
Custodis, Florian ;
Baumhaekel, Magnus ;
Schlimmer, Nils ;
List, Franka ;
Gensch, Christoph ;
Boehm, Michael ;
Laufs, Ulrich .
CIRCULATION, 2008, 117 (18) :2377-2387
[13]   Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease [J].
Diaz, A ;
Bourassa, MG ;
Guertin, MC ;
Tardif, JC .
EUROPEAN HEART JOURNAL, 2005, 26 (10) :967-974
[15]   Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice [J].
Drouin, A. ;
Gendron, M-E ;
Thorin, E. ;
Gillis, M-A ;
Mahlberg-Gaudin, F. ;
Tardif, J-C .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (04) :749-757
[16]   Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts Male Aging Study [J].
Feldman, HA ;
Johannes, CB ;
Derby, CA ;
Kleinman, IC ;
Mohr, BA ;
Araujo, AB ;
McKinlay, JB .
PREVENTIVE MEDICINE, 2000, 30 (04) :328-338
[17]   IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].
FELDMAN, HA ;
GOLDSTEIN, I ;
HATZICHRISTOU, DG ;
KRANE, RJ ;
MCKINLAY, JB .
JOURNAL OF UROLOGY, 1994, 151 (01) :54-61
[18]   Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial [J].
Fox, Kim ;
Ford, Ian ;
Steg, P. Gabriel ;
Tendera, Michal ;
Ferrari, Roberto .
LANCET, 2008, 372 (9641) :807-816
[19]   Cellular and molecular mechanisms of endothelial cell dysfunction [J].
Harrison, DG .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2153-2157
[20]   HEART-RATE AND CARDIOVASCULAR MORTALITY - THE FRAMINGHAM-STUDY [J].
KANNEL, WB ;
KANNEL, C ;
PAFFENBARGER, RS ;
CUPPLES, LA .
AMERICAN HEART JOURNAL, 1987, 113 (06) :1489-1494